{
    "Trade/Device Name(s)": [
        "Emit II Plus Oxycodone Assay",
        "Emit\u00ae II Plus Oxycodone Assay"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K172910",
    "Predicate Device Reference 510(k) Number(s)": [
        "K040411"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG"
    ],
    "Summary Letter Date": "September 21, 2017",
    "Summary Letter Received Date": "September 25, 2017",
    "Submission Date": "October 16, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.3650"
    ],
    "Regulation Name(s)": [
        "Opiate test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Oxycodone"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Viva-E analyzer",
        "Clinical chemistry analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay"
    ],
    "Methodologies": [
        "Homogeneous enzyme immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Emit II Plus Oxycodone Assay, a homogeneous enzyme immunoassay for qualitative and semiquantitative determination of oxycodone in human urine",
    "Indications for Use Summary": "For in vitro diagnostic use in the qualitative and semiquantitative determination of oxycodone in human urine, providing preliminary analytical test results; designed for use with clinical chemistry analyzers",
    "fda_folder": "Toxicology"
}